Open letter to Senator Klobuchar regarding price spikes in insulin and other pharmaceuticals and medical devices
by Glen Wallace
Hi Senator Klobuchar, I just saw a feature on the KSTP news featuring some comments by you about the recent run-up in the price of insulin recently. I believe an ideal solution is one you and your colleagues on capitol hill have not even considered legislatively. The solution to spikes in the price of pharmaceuticals and medical devices would be for the government to take over the production and distribution of those pharmaceuticals and medical devices at cost. Currently there seems to be a habit of thinking among healthcare policy makers that traps them into assuming that the only option to getting a needed healthcare product to the patient is by way of the commercial markets.
But there shouldn’t be any barriers to the federal government taking on the role of the production and distribution of at least the medicines and devices that are outside of patent protection. And keep in mind many of the most notorious recent cases of price spikes occurred with products that were already outside of patent protection — including, but not limited to insulin and the epipen.
Also, there is a long standing precedent of the federal government owning and operating the means of production and distribution of a product — the Government Publishing Office, formerly known as the Government Printing Office, has been around for many decades manufacturing, printing, publishing and selling to individuals and institutions everything from books to pamphlets to posters and just about everything printable in between.
Therefore, there should be nothing stopping the Senate and House from mandating the opening of a Government Pharmaceutical and Medical Devices Office to bypass the market and get the needed healthcare products directly to the patients at the mere cost of production.
For years now I have been seeing hearings and statements from representatives such as yourself ranging from scolding to pleading of manufacturers to try and keep their prices down. I ask you; who’s in charge here? When I hear only talk from you in the form of scolding and pleading to some Big Pharma executive, it sure looks like it is the Big Pharma companies that are the ones in charge. I thought we were a country of, by and for the people. If they will not bring the prices down, then we the people should engage that American can-do spirit, and make those products ourselves.
And this could be just the beginning — we could start building a medical system that is entirely patient driven instead of where it is now in being market driven. I think people that go into the medical profession do it first and foremost because they care about people. With a patient driven, patient based system we can have as the primary decision makers, about what medical drug or device goes into production and their prices, be those medical professionals that care about the patients and not some bean counting CEO with only a legal fiduciary responsibility to some distant shareholders.